e7 Health offers the HIB Vaccine
Haemophilus influenza type B (HIB)
Haemophilus influenza type B (HIB) is a bacterium that causes infection that is particularly severe among infants and children under five years of age. It is thought to be spread through respiratory droplets in the air and can spread from person to person.
HIB infection can lead to serious complications such as meningitis, pneumonia, skin infections, inflammation of the epiglottis, and death. Symptoms of meningitis include fever, stiffness in the neck, hearing loss, and an altered mental state and it is the most common complication of HIB infection accounting for more than half of all cases before the vaccine was made available.
HIB disease has been tracked since the 1980s when it was estimated that approximately 20,000 cases of HIB infection occurred annually in the United States alone. Most of these cases were in children under five years of age. That incident rate dramatically reduced when HIB vaccine was made available in the late 1980s. In 2009, between 35 and 213 cases of HIB infection were reported in the United States. Almost all of the cases seen today are among children who are unvaccinated or undervaccinated against HIB. Since the release of the HIB vaccine, the incidence of HIB infection has been reduced by more than 99%.
Since HIB infection largely affects children under five years of age, HIB vaccine is recommended for all children starting at 2 months of age. HIB vaccine is also recommended for:
- Children and adults who are having surgery to remove the spleen.
- Individuals who are going to undergo a bone marrow transplant.
- Individuals with certain health conditions such as HIV/AIDS and sickle cell disease.
- Other individuals as recommended by their doctor.
Download Vaccine Information Statements (VIS)
e7 Health has ALL the recommended and/or required vaccines needed for your travel: